New Data Reported From Trials of Drug Developed at Yale Pathology to Treat Rare, Often Fatal Neonatal Disorder
Clinical trial data from an enzyme-therapy drug developed at Yale Pathology to treat a rare and often fatal neonatal calcification disorder were recently reported. The drug, INZ-701, was designed and validated in the laboratory of Demetrios Braddock, MD, PhD, Associate Professor of Pathology at Yale School of Medicine.
Breastmilk tracking app shows promising results at YNHH Bridgeport campus
Eliza Myers’s app idea earned her the Innovator Award from the YNHHS Center for Health Care Innovation. Now, the app is ensuring increased human milk access for newborn babies — and, for parents, newfound agency in the breastfeeding process.Source: Yale Daily News
Premature babies: 'Most will do very well,' says expert
When babies are born prematurely, caregivers and hospital staff rightly worry. However, as Dr. Mercurio, a professor of neonatology from Yale School of Medicine, explains, ‘the outcomes will be good’ for most of these babies.Source: Medical News Today
National-Perinatal COVID-19 Registry
The Yale Neonatal Research Team is excited to announce their involvement the National Perinatal COVID-19 Registry. The registry is a collaboration between the AAP, the Vermont-Oxford Network, and MedNAX, and aims to collect national data regarding transmission risk between mother and infant